
Cyient Q3 Results 2026 Highlights: Net Profit Falls by 24.94% & Revenue Down 4.04% YoY
Updated: 24 Jan 2026 • 3:32 pm
Posted by:

Click and Sign Up to Get Live Updates on Q3 Results
Cyient Q3 Results FY26: During Q3 FY26, Cyient’s profit decreased by 24.94% YoY, while revenue decreased by 4.04% YoY. The company posted robust numbers, with Q3 PAT at ₹91.80 crores and revenue at ₹1,848.50 crores. Cyient showed its Q3 results on 22nd January 2026.
Cyient Q3 Results FY26: Extracts of FY25 & FY26
| Particulars | Consolidated Figures | Standalone Figures | ||
| 31st Dec 2025 | 31st Dec 2024 | 31st Dec 2025 | 31st Dec 2024 | |
| Revenue from Operations | ₹1,848.50 | ₹1,926.40 | ₹600.90 | ₹612.50 |
| Profit Before Tax (PBT) | ₹268.10 | ₹262.30 | ₹188.60 | ₹119.40 |
| Profit After Tax (PAT) | ₹91.80 | ₹122.30 | -₹145.70 | ₹71.30 |
Cyient Q3 Results FY26 Highlights (Q3 FY26 vs FY25)
- Cyient clocked Q3 FY26 consolidated revenue of ₹1,848.50 crores vs ₹1,926.40 crores.
- On the profit front, Cyient earned a consolidated PAT of ₹91.80 crore in Q3 FY26. During FY25, the company’s PAT stood at ₹122.30 crore.
- According to the consolidated figures, Cyient’s quarterly PAT decreased by 24.94% YoY, while revenue decreased by 4.04%.
- Cyient clocked Q3 FY26 standalone revenue of ₹600.90 crores vs ₹612.50 crores.
- On the profit front, Cyient earned a standalone PAT of -₹145.70 crore in Q3 FY26. During FY25, the company’s PAT stood at ₹71.30 crore.
- According to the standalone figures, Cyient’s quarterly PAT decreased by 304.35% YoY, while revenue decreased by 1.89%.
Download the Univest iOS App or Univest Android App to get daily stock recommendations and insightful research pieces!
Cyient Share Price Performance
On the opening bell on 23rd January 2026, Cyient shares opened at ₹1,125.40 per share. However, the initial gains have since eroded, and Cyient’s shares are currently trading at ₹1,087.90 per share, which is lower than the opening price.
Considering the long-term performance, Cyient shares have yielded returns of approximately -15.03% over the past 6 months and -38.02% over the past 1 year. Over the maximum timeframe, Cyient shares delivered a 8,412.52% return to investors.
What Analysts Expect Post Q3 Results?
Following Cyient’s robust Q3 results for FY26, analysts expect its share price to rise. According to analysts, Cyient’s share price could reach ₹1,100.90 per share in the coming year and, in a downturn, hit ₹1,650.90 per share. However, one must ignore stock market volatility and invest in Cyient shares after thorough research.
Disclaimer: Investment in the share market is subject to risk. This news article is for informational purposes only. Conduct your own research before investing in shares and other securities.
Recent Articles
Aritas Vinyl IPO GMP & Subscription Status: Day 2
Recent Articles

LT Foods Q4 FY26 Results: PAT of Rs 135.67 crore Basmati Rice and Food Products
15 May 2026

Muthoot Finance Q4 FY26 Results: PAT of Rs 10,607 (FY26 consolidated annual) crore (up 98% Yo Gold Loan NBFC
15 May 2026

Alivus Life Sciences Q4 FY26 Results: Announced May 14 2026 Pharma API and CDMO – Formerly Glenmark Life Sciences
15 May 2026

Chalet Hotels Q4 FY26 Results: Announced May 14 2026 Luxury and Business Hotels
15 May 2026
Note: This blog is for information purpose only. Investments and trading are subject to market risks, read all scheme related documents carefully.
Reviews
Recent Posts
LT Foods Q4 FY26 Results: PAT of Rs 135.67 crore Basmati Rice and Food Products
Muthoot Finance Q4 FY26 Results: PAT of Rs 10,607 (FY26 consolidated annual) crore (up 98% Yo Gold Loan NBFC
Alivus Life Sciences Q4 FY26 Results: Announced May 14 2026 Pharma API and CDMO – Formerly Glenmark Life Sciences
Chalet Hotels Q4 FY26 Results: Announced May 14 2026 Luxury and Business Hotels
Tata Motors Passenger Vehicles Q4 FY26 Results: PAT of Rs 2,406 (standalone Tata Motors) crore (up 69.55% Yo Passenger Vehicles and EV
Popular this week
LT Foods Q4 FY26 Results: PAT of Rs 135.67 crore Basmati Rice and Food Products
Muthoot Finance Q4 FY26 Results: PAT of Rs 10,607 (FY26 consolidated annual) crore (up 98% Yo Gold Loan NBFC
Alivus Life Sciences Q4 FY26 Results: Announced May 14 2026 Pharma API and CDMO – Formerly Glenmark Life Sciences
Chalet Hotels Q4 FY26 Results: Announced May 14 2026 Luxury and Business Hotels
Tata Motors Passenger Vehicles Q4 FY26 Results: PAT of Rs 2,406 (standalone Tata Motors) crore (up 69.55% Yo Passenger Vehicles and EV

Uniresearch Global Pvt Ltd
Research Analyst
SEBI Registration Number — INH000013776
Uniresearch is a subsidiary of Univest Communication Technologies Private Limited
Company Address: Registered Address: Ground Floor, Unitech Commercial Tower 2, Block B, Greenwood City, Unit 1-3, Sector 45, Gurugram, Haryana 122003
Write to us : support@univest.in, compliance@univest.in
Verify on SEBI registry →RESEARCH ANALYST
Get SEBI Registered
advice on the stocks
trending today.
Get 3 FREE Trade Ideas





